About Prime Pharmaceuticals Private Limited
Data last updated:
Prime Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 11 September 1995 and has been in existence for over 31 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24231MH1995PTC092543. Its GSTIN is 27AABCP6584G1Z5 (Maharashtra). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹61.84 Lakh. It was formerly known as Prime Pharmaceuticals Limited. It is led by directors including Devang Subodh Thakar and Manish Patel.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 601 6th Floor Kamla Executive Park, Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹148.64 Cr, a growth of 131% compared to the previous year. For the same year it recorded a net profit of ₹8.78 Cr (net margin 5.9%) and EBITDA of ₹17.53 Cr (EBITDA margin 11.8%).
The company has about 46 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹85 Cr and satisfied charges of ₹17.35 Cr on record. Court records list 3 cases involving the company, including 3 filed by the company. The company has 7 deals on record (6 secondary share transfers, 1 rights issue); the latest was in March 2023. Its 10 peer companies in the Pharma industry (Formulations, Pharmaceuticals) are compared by revenue, 5 larger and 5 smaller; the largest is Gufic Biosciences Limited with revenue of ₹823.43 Cr. The company has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 23 overdue payments to 10 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website primepharma.com.
CIN History of Prime Pharmaceuticals Private Limited
Prime Pharmaceuticals has one previous CIN (Corporate Identification Number): U24231MH1995PLC092543. The current CIN is U24231MH1995PTC092543, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24231MH1995PTC092543 | Current |
| U24231MH1995PLC092543 | Previous |
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered Address601 6th Floor Kamla Executive Park, A K Road Andheri East, Mumbai, Maharashtra, India – 400059
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Prime Pharmaceuticals Private Limited
The main business activity of Prime Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Prime Pharmaceuticals Private Limited FY 2025 filings available
Prime Pharmaceuticals Private Limited reported revenue of ₹148.64 Cr (up 131% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Prime Pharmaceuticals Private Limited
Revenue rose 131% in the latest year. EBITDA rose 9% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Prime Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | ₹148.64 Cr | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹17.53 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹8.78 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Prime Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 5.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Prime Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Prime Pharmaceuticals Private Limited
Prime Pharmaceuticals has 6 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Devang Subodh Thakar | Director | 02 Apr 1998 | 28 Years 6 Months | Current |
| Manish Patel | Director | 02 Apr 1998 | 28 Years 6 Months | Current |
| Manish Navnitrai Vora Also directs: Odon Prime Pharma Private Limited | Director | 23 May 2024 | 2 Years 4 Months | Current |
| Ramamurthy Ayyavuthevar | Director | 05 Feb 2021 | 5 Years 8 Months | Current |
| Ashish Anil Vora Also directs: Regenix Biosciences Limited, Odon Prime Pharma Private Limited | Director | 11 Sep 1995 | 31 Years 1 Months | Current |
| Irfan Vazirally | Director | 20 May 2022 | 4 Years 5 Months | Current |
Peer Comparison of Prime Pharmaceuticals Private Limited
Prime Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Gufic Biosciences Limited Listed | ₹823.43 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | Mumbai, Maharashtra, India |
| Medinote Distributors Private Limited | ₹819.71 Cr (FY 2025) | •••• | •••• | •••• | New Delhi, Delhi, India | |
| Abil Chempharma Private Limited | ₹795.2 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Mumbai, Maharashtra, India |
| Synokem Pharmaceuticals Limited | ₹791.15 Cr (FY 2025) | •••• | •••• | 0.0% | •••• | New Delhi, Delhi, India |
| SMS Pharmaceuticals Limited Listed | ₹788.97 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | Hyderabad, Telangana, India |
| Windlas Biotech Limited Listed | ₹777.9 Cr (FY 2025) | •••• | •••• | 21.0% | •••• | Dehradun, Uttarakhand, India |
| Fourrts (India) Laboratories Private Limited | ₹760.55 Cr (FY 2024) | •••• | •••• | 7.0% | •••• | Chennai, Tamil Nadu, India |
| Pritam International Private Limited | ₹758.46 Cr (FY 2025) | •••• | •••• | 15.0% | •••• | Kolkata, West Bengal, India |
| Indchemie Health Specialities Private Limited | ₹734.44 Cr (FY 2025) | •••• | •••• | 5.0% | •••• | Mumbai, Maharashtra, India |
| Sanofi-Synthelabo (India) Private Limited | ₹729.49 Cr (FY 2020) | •••• | •••• | 16.0% | •••• | Mumbai, Maharashtra, India |
| Prime Pharmaceuticals Private Limited this company | ₹148.64 Cr (FY 2025) | •••• | •••• | 131.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Prime Pharmaceuticals by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Prime Pharmaceuticals Private Limited
Prime Pharmaceuticals Private Limited is audited by HEGDE & ASSOCIATES for the financial year 2025.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| HEGDE & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Prime Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Prime Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Nov 2024 | Others | ₹20 Cr | Open |
| 18 May 2023 | Citi Bank N.A. | ₹65 Cr | Open |
| 17 Jul 2021 | Others | ₹50 Lakh | Satisfied |
| 25 May 2021 | Others | ₹75 Lakh | Satisfied |
| 06 May 2017 | Others | ₹10.5 Cr | Satisfied |
Total charge records: 17 View all charges
Deals & Funding of Prime Pharmaceuticals Private Limited
Prime Pharmaceuticals Private Limited has 7 deals on record (6 secondary share transfers, 1 rights issue); the latest was in March 2023.
Deals on record (5 of 7)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2023 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 2 individuals |
| Sep 2022 | Rights issue | ₹10 Lakh | Investors: 3 individuals |
| Mar 2022 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: 4 individuals |
| Mar 2022 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Sep 2012 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: 2 individuals |
Full deal history
All 7 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Prime Pharmaceuticals Private Limited
Prime Pharmaceuticals Private Limited has 3 court cases on record: 3 filed by Prime Pharmaceuticals. All cases are disposed. Status as checked between 02 Oct 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 3 | 0 | 0 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Gujarat | Commercial suit | Filed by the company against Ambalal Sarabhai Enterprises Limited | Disposed |
| High Court of Gujarat | Commercial suit | Filed by the company against Synbiotics Limited | Disposed |
| High Court of Gujarat | Court case (COMP) | Filed by the company against Ambalal Sarabhai Enterprises Limited | Disposed |
Full case history
All 3 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Prime Pharmaceuticals Private Limited
Prime Pharmaceuticals Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 23 overdue payments to 10 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 10)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Chase Logistics Private Limited | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| Macro Logistics & Exim Private Limited | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| Dhruvi Offset | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 1 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at Prime Pharmaceuticals Private Limited
Prime Pharmaceuticals Private Limited has a workforce of 46 employees as of Jan 09, 2026.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Prime Pharmaceuticals Private Limited
Prime Pharmaceuticals Private Limited has 10 board changes on record since 1995: 6 appointments and 4 cessations. The latest: Manish Navnitrai Vora ceased to be Additional Director on 29 Sep 2024.
38 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Prime Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Prime Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Prime Pharmaceuticals Private Limited
Prime Pharmaceuticals has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCP6584G1Z5 | Maharashtra | Active | 01 Jul 2017 |
| 24AABCP6584G1ZB | Gujarat | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Prime Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Related news about Prime Pharmaceuticals Private Limited
Frequently Asked Questions about Prime Pharmaceuticals Private Limited
Prime Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 11 September 1995 (31+ years old) and is registered under CIN U24231MH1995PTC092543.
Prime Pharmaceuticals reported revenue of ₹148.64 Cr for FY 2025 (up 131% YoY).
Prime Pharmaceuticals has 6 current directors:
- Devang Subodh Thakar - Director
- Manish Patel - Director
- Manish Navnitrai Vora - Director
- Ramamurthy Ayyavuthevar - Director
- Ashish Anil Vora - Director
- Irfan Vazirally - Director
Prime Pharmaceuticals reported a net profit of ₹8.78 Cr (net margin 5.9%) and EBITDA of ₹17.53 Cr (EBITDA margin 11.8%) for FY 2025, as per its filed financial statements.
The GSTIN of Prime Pharmaceuticals is 27AABCP6584G1Z5, registered in Maharashtra. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 24AABCP6584G1ZB (Gujarat).
The CIN (Corporate Identification Number) of Prime Pharmaceuticals is U24231MH1995PTC092543. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Prime Pharmaceuticals has 3 court cases on record: 3 filed by the company.
Prime Pharmaceuticals was incorporated on 11 September 1995, making it 31+ years old. It is registered with the Registrar of Companies, Mumbai.
Prime Pharmaceuticals has 7 deals on record (6 secondary share transfers, 1 rights issue); the latest was in March 2023.
The peers of Prime Pharmaceuticals by revenue are Gufic Biosciences Limited, Medinote Distributors Private Limited, Abil Chempharma Private Limited, Synokem Pharmaceuticals Limited, SMS Pharmaceuticals Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).
Manish Navnitrai Vora ceased to be Additional Director on 29 Sep 2024. Manish Navnitrai Vora was appointed as Director on 23 May 2024. Ramamurthy Ayyavuthevar ceased to be Additional Director on 30 Sep 2022. Prime Pharmaceuticals has 10 board changes on record in total.
Prime Pharmaceuticals has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 23 overdue payments to 10 micro and small suppliers. The latest return was filed on 02 Jul 2024.